Immunocore Holdings plc ADR (IMCR)
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 29.41 0.00%
IMCR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.51B
- EPS (TTM)
- -$0.36
- Dividend yield
- None
- 52-week range
- 27.56 – 40.72
- Day range
- 29.15 – 29.82
- Volume / Avg
- 343.75K / 449.06K
- Beta
- —
- Shares outstanding
- 51.50M
- Next earnings
- Nov 5, 2026
52-week range
IMCR stock today
Shares of Immunocore (IMCR) finished lower on Oct 7 at $29.41, a drop of 0.47% or $0.14 per share, versus the S&P 500's 0.22% decline. Shares are 27.8% below their 52-week high of $40.72, set on Dec 5, 2025 and 6.7% above the 52-week low of $27.56, near the bottom of the past year's range. IMCR is down 15.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 14.1%.
Immunocore has posted a net loss over the last twelve months (EPS of -$0.36), so its P/E ratio is not meaningful. Immunocore's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Immunocore
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.10
Immunocore peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MAZEMaze Therapeutics Inc. | 26.25 | -0.68% | $1.46B | vs IMCR |
| TSHATaysha Gene Therapies Inc. | 4.43 | +0.91% | $1.44B | vs IMCR |
| INBXInhibrx Biosciences Inc. | 93.36 | -0.05% | $1.37B | vs IMCR |
| COAGHemab Therapeutics Holdings Inc. | 28.70 | +1.16% | $1.34B | vs IMCR |
| REPLReplimune Group Inc. | 13.20 | -0.38% | $1.24B | vs IMCR |
| IMTXImmatics N.V. | 7.45 | -0.67% | $1.13B | vs IMCR |
| VORVor Biopharma Inc. | 18.78 | +2.57% | $1.11B | vs IMCR |
| MGTXMeiraGTx Holdings plc | 10.82 | +2.08% | $1.04B | vs IMCR |
Indexes, lists and sector
Largest Health Care stocks
Immunocore stock FAQ
What is Immunocore's stock price today?
IMCR last traded at $29.41 as of Oct 7, 4:00 PM EDT, down 0.47% on the day. Prices are delayed at least 15 minutes.
When is Immunocore's next earnings date?
Immunocore is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.10.
What is the IMCR 52-week high?
The 52-week high for IMCR is $40.72 and the 52-week low is $27.56. The stock is currently 27.8% below its high.